301 related articles for article (PubMed ID: 30018119)
1. Cytokines Produced by Dendritic Cells Administered Intratumorally Correlate with Clinical Outcome in Patients with Diverse Cancers.
Subbiah V; Murthy R; Hong DS; Prins RM; Hosing C; Hendricks K; Kolli D; Noffsinger L; Brown R; McGuire M; Fu S; Piha-Paul S; Naing A; Conley AP; Benjamin RS; Kaur I; Bosch ML
Clin Cancer Res; 2018 Aug; 24(16):3845-3856. PubMed ID: 30018119
[No Abstract] [Full Text] [Related]
2. Intratumoral injection of dendritic cells derived in vitro in patients with metastatic cancer.
Triozzi PL; Khurram R; Aldrich WA; Walker MJ; Kim JA; Jaynes S
Cancer; 2000 Dec; 89(12):2646-54. PubMed ID: 11135227
[TBL] [Abstract][Full Text] [Related]
3. Phase I Trial of Intratumoral Injection of
Lee JM; Lee MH; Garon E; Goldman JW; Salehi-Rad R; Baratelli FE; Schaue D; Wang G; Rosen F; Yanagawa J; Walser TC; Lin Y; Park SJ; Adams S; Marincola FM; Tumeh PC; Abtin F; Suh R; Reckamp KL; Lee G; Wallace WD; Lee S; Zeng G; Elashoff DA; Sharma S; Dubinett SM
Clin Cancer Res; 2017 Aug; 23(16):4556-4568. PubMed ID: 28468947
[No Abstract] [Full Text] [Related]
4. Intratumoral injection of IFN-alpha dendritic cells after dacarbazine activates anti-tumor immunity: results from a phase I trial in advanced melanoma.
Rozera C; Cappellini GA; D'Agostino G; Santodonato L; Castiello L; Urbani F; Macchia I; Aricò E; Casorelli I; Sestili P; Montefiore E; Monque D; Carlei D; Napolitano M; Rizza P; Moschella F; Buccione C; Belli R; Proietti E; Pavan A; Marchetti P; Belardelli F; Capone I
J Transl Med; 2015 May; 13():139. PubMed ID: 25933939
[TBL] [Abstract][Full Text] [Related]
5. Intratumorally injected pro-inflammatory allogeneic dendritic cells as immune enhancers: a first-in-human study in unfavourable risk patients with metastatic renal cell carcinoma.
Laurell A; Lönnemark M; Brekkan E; Magnusson A; Tolf A; Wallgren AC; Andersson B; Adamson L; Kiessling R; Karlsson-Parra A
J Immunother Cancer; 2017; 5():52. PubMed ID: 28642820
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of metastatic melanoma by intratumoral injections of Vero cells producing human IL-2: phase II randomized study comparing two dose levels.
Rochlitz C; Dreno B; Jantscheff P; Cavalli F; Squiban P; Acres B; Baudin M; Escudier B; Heinzerling L; Morant R; Herrmann R; Dietrich PY; Dummer R
Cancer Gene Ther; 2002 Mar; 9(3):289-95. PubMed ID: 11896446
[TBL] [Abstract][Full Text] [Related]
7. Intratumoral CpG-B Promotes Antitumoral Neutrophil, cDC, and T-cell Cooperation without Reprograming Tolerogenic pDC.
Humbert M; Guery L; Brighouse D; Lemeille S; Hugues S
Cancer Res; 2018 Jun; 78(12):3280-3292. PubMed ID: 29588348
[TBL] [Abstract][Full Text] [Related]
8. Intratumoral Injection of
Janku F; Zhang HH; Pezeshki A; Goel S; Murthy R; Wang-Gillam A; Shepard DR; Helgason T; Masters T; Hong DS; Piha-Paul SA; Karp DD; Klang M; Huang SY; Sakamuri D; Raina A; Torrisi J; Solomon SB; Weissfeld A; Trevino E; DeCrescenzo G; Collins A; Miller M; Salstrom JL; Korn RL; Zhang L; Saha S; Leontovich AA; Tung D; Kreider B; Varterasian M; Khazaie K; Gounder MM
Clin Cancer Res; 2021 Jan; 27(1):96-106. PubMed ID: 33046513
[TBL] [Abstract][Full Text] [Related]
9. Improving immunological tumor microenvironment using electro-hyperthermia followed by dendritic cell immunotherapy.
Tsang YW; Huang CC; Yang KL; Chi MS; Chiang HC; Wang YS; Andocs G; Szasz A; Li WT; Chi KH
BMC Cancer; 2015 Oct; 15():708. PubMed ID: 26472466
[TBL] [Abstract][Full Text] [Related]
10. Dendritic cell gene therapy.
Onaitis M; Kalady MF; Pruitt S; Tyler DS
Surg Oncol Clin N Am; 2002 Jul; 11(3):645-60. PubMed ID: 12487060
[TBL] [Abstract][Full Text] [Related]
11. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
da Cunha A; Antoniazi Michelin M; Cândido Murta EF
Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
[TBL] [Abstract][Full Text] [Related]
12. CD40ligand-expressing dendritic cells induce regression of hepatocellular carcinoma by activating innate and acquired immunity in vivo.
Gonzalez-Carmona MA; Lukacs-Kornek V; Timmerman A; Shabani S; Kornek M; Vogt A; Yildiz Y; Sievers E; Schmidt-Wolf IG; Caselmann WH; Sauerbruch T; Schmitz V
Hepatology; 2008 Jul; 48(1):157-68. PubMed ID: 18537185
[TBL] [Abstract][Full Text] [Related]
13. Open-label, multi-center, non-randomized, single-arm study to evaluate the safety and efficacy of dendritic cell immunotherapy in patients with refractory solid malignancies, on supportive care.
Bapsy PP; Sharan B; Kumar C; Das RP; Rangarajan B; Jain M; Suresh Attili VS; Subramanian S; Aggarwal S; Srivastava M; Vaid A
Cytotherapy; 2014 Feb; 16(2):234-44. PubMed ID: 24438902
[TBL] [Abstract][Full Text] [Related]
14. Intratumoral administration of adenoviral interleukin 7 gene-modified dendritic cells augments specific antitumor immunity and achieves tumor eradication.
Miller PW; Sharma S; Stolina M; Butterfield LH; Luo J; Lin Y; Dohadwala M; Batra RK; Wu L; Economou JS; Dubinett SM
Hum Gene Ther; 2000 Jan; 11(1):53-65. PubMed ID: 10646639
[TBL] [Abstract][Full Text] [Related]
15. Upregulation of natural killer cells functions underlies the efficacy of intratumorally injected dendritic cells engineered to produce interleukin-12.
Rodríguez-Calvillo M; Duarte M; Tirapu I; Berraondo P; Mazzolini G; Qian C; Prieto J; Melero I
Exp Hematol; 2002 Mar; 30(3):195-204. PubMed ID: 11882356
[TBL] [Abstract][Full Text] [Related]
16. The boosting effect of co-transduction with cytokine genes on cancer vaccine therapy using genetically modified dendritic cells expressing tumor-associated antigen.
Ojima T; Iwahashi M; Nakamura M; Matsuda K; Naka T; Nakamori M; Ueda K; Ishida K; Yamaue H
Int J Oncol; 2006 Apr; 28(4):947-53. PubMed ID: 16525645
[TBL] [Abstract][Full Text] [Related]
17. Intratumoral injection of dendritic cells overexpressing interleukin‑12 inhibits melanoma growth.
Yao W; Li Y; Zeng L; Zhang X; Zhou Z; Zheng M; Wan H
Oncol Rep; 2019 Jul; 42(1):370-376. PubMed ID: 31115558
[TBL] [Abstract][Full Text] [Related]
18. Tumor Microenvironment Remodeling by Intratumoral Oncolytic Vaccinia Virus Enhances the Efficacy of Immune-Checkpoint Blockade.
Chon HJ; Lee WS; Yang H; Kong SJ; Lee NK; Moon ES; Choi J; Han EC; Kim JH; Ahn JB; Kim JH; Kim C
Clin Cancer Res; 2019 Mar; 25(5):1612-1623. PubMed ID: 30538109
[TBL] [Abstract][Full Text] [Related]
19. Combination of conformal radiotherapy and intratumoral injection of adoptive dendritic cell immunotherapy in refractory hepatoma.
Chi KH; Liu SJ; Li CP; Kuo HP; Wang YS; Chao Y; Hsieh SL
J Immunother; 2005; 28(2):129-35. PubMed ID: 15725956
[TBL] [Abstract][Full Text] [Related]
20. Low-dose paclitaxel prior to intratumoral dendritic cell vaccine modulates intratumoral cytokine network and lung cancer growth.
Zhong H; Han B; Tourkova IL; Lokshin A; Rosenbloom A; Shurin MR; Shurin GV
Clin Cancer Res; 2007 Sep; 13(18 Pt 1):5455-62. PubMed ID: 17875775
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]